Compared to obese patients with NAFLD, non-obese patients had decreased waist circumference (34.1 ± 10.6 vs. 37.3 ± 4.1 inches, p < 0.001); WBC count (6.2 ± 1.7 vs. 7.5 ± 1.5 × 109/L, p = 0.01); and ALT levels (34.9 ± 17.0 vs. 55.6 ± 49.6 IU/L, p = 0.03). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.